InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

Current share price for RAD : $0.012 0.001 (7.69%)+

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Share Purchase Plan - Now Open 7 Aug 2026 9:38AM $0.013 $0.012 fallen by 7.69%
$52 Update - Proposed issue of securities - RAD 5 Aug 2026 1:56PM $0.013 $0.012 fallen by 7.69%
$52 Application for quotation of securities - RAD 3 Aug 2026 10:51AM $0.013 $0.012 fallen by 4%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 11:19AM $0.013 $0.012 fallen by 7.69%
$52 Change in substantial holding 30 Jul 2026 4:48PM $0.014 $0.012 fallen by 14.29%
$52 Target market determination (TMD) 30 Jul 2026 4:32PM $0.014 $0.012 fallen by 14.29%
$52 Prospectus 30 Jul 2026 4:25PM $0.014 $0.012 fallen by 14.29%
$52 Notice Under Section 708A 28 Jul 2026 4:19PM $0.015 $0.012 fallen by 20%
$52 Application for quotation of securities - RAD 28 Jul 2026 10:53AM $0.015 $0.012 fallen by 20%
$52 Reinstatement to Quotation 24 Jul 2026 5:21PM $0.019 $0.012 fallen by 36.84%
$52 Investor Presentation - Capital Raising 24 Jul 2026 5:21PM $0.019 $0.012 fallen by 36.84%
$52 Proposed issue of securities - RAD 24 Jul 2026 5:21PM $0.019 $0.012 fallen by 36.84%
$52 Proposed issue of securities - RAD 24 Jul 2026 5:20PM $0.019 $0.012 fallen by 36.84%
$52 RAD completes A$12.5 M placement and launches A$6 M SPP 24 Jul 2026 5:20PM $0.019 $0.012 fallen by 36.84%
$52 Suspension from Quotation 24 Jul 2026 9:14AM $0.019 $0.012 fallen by 36.84%
$52 Trading Halt 22 Jul 2026 9:04AM $0.019 $0.012 fallen by 36.84%
$52 RAD Achieves Partial Response in Phase 1 Trial of RAD204 22 Jul 2026 8:32AM $0.019 $0.012 fallen by 36.84%
$52 RAD Announces Positive Phase 2b Trial Results of RAD 101 22 Jul 2026 8:22AM $0.019 $0.012 fallen by 36.84%
$52 Radiopharm Receives $5.9M R&D Tax Incentive 3 Jul 2026 3:20PM $0.019 $0.012 fallen by 36.84%
$52 Notification regarding unquoted securities - RAD 30 Jun 2026 4:15PM $0.019 $0.012 fallen by 36.84%
$52 Notification of cessation of securities - RAD 30 Jun 2026 4:05PM $0.020 $0.012 fallen by 38.46%
$52 Notification of cessation of securities - RAD 3 Jun 2026 12:08PM $0.019 $0.012 fallen by 36.84%
$52 Financial Services and Company Secretary Changes 1 May 2026 9:53AM $0.019 $0.012 fallen by 36.84%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 23 Apr 2026 9:04AM $0.021 $0.012 fallen by 42.86%
$52 RAD Initial Findings from Phase 1 177Lu-RAD202 Trial 20 Apr 2026 8:54AM $0.021 $0.012 fallen by 41.46%

1 - 25 of 609 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.